TGFB1 and lung adenocarcinoma: For lung adenocarcinoma, it was reported that LDRT could boost the antitumor efficacy of ICBs by promoting the polarization of M1-type TAMs, increasing the infiltration of natural killer cells (NKs), and decreasing TGF-β levels in both preclinical and clinical investigations18.